Impact of hormone replacement therapy on the histologic subtype of breast cancer

Archives of Gynecology and Obstetrics

Volumn 278, Issue 5, 2008, Pages 443-449

  Zanetti Dällenbach, Rosanna A ^a   Krause, Elke M ^b   Lapaire, Olav ^a   Gueth, Uwe ^a   Holzgreve, Wolfgang ^a   Wight, Edward ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Breast cancer; Histologic subtype; Hormone replacement therapy (HRT)

Indexed keywords

ESTROGEN; GESTAGEN; TIBOLONE;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST DUCT; CANCER INVASION; CANCER RISK; CARCINOMA IN SITU; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DUCTAL BREAST CANCER; FAMILY HISTORY; FEMALE; HISTOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LOBULAR BREAST CANCER; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENOPAUSAL SYNDROME; MENOPAUSE; MONOTHERAPY; OVARIECTOMY; POSTMENOPAUSE; PRIMARY TUMOR; SWITZERLAND; TREATMENT DURATION; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 51449087357     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0613-8     Document Type: Article

References (52)

1. Anonymous (1997) Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative group on hormonal factors in breast cancer. Lancet 350:1047-1059
2. G Arpino VJ Bardou GM Clark RM Elledge 2004 Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome Breast Cancer Res 6 R149 R156
3. E Banks 2001 Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review J Med Screen 8 29 34
4. V Beral 2003 Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 419 427
5. V Beral E Banks G Reeves 2002 Evidence from randomised trials on the long-term effects of hormone replacement therapy Lancet 360 942 944
6. WA Berg L Gutierrez MS NessAiver WB Carter M Bhargavan RS Lewis OB Ioffe 2004 Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer Radiology 233 830 849
7. NF Boyd JW Byng RA Jong EK Fishell LE Little AB Miller GA Lockwood DL Tritchler MJ Yaffe 1995 Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study J Natl Cancer Inst 87 670 675
8. NF Boyd LJ Martin Q Li L Sun AM Chiarelli G Hislop MJ Yaffe S Minkin 2006 Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer Cancer Epidemiol Biomarkers Prev 15 961 966
9. KM Brett JH Madans 1997 Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study Am J Epidemiol 145 536 545
10. RS Butler LA Venta EL Wiley RL Ellis PJ Dempsey E Rubin 1999 Sonographic evaluation of infiltrating lobular carcinoma AJR Am J Roentgenol 172 325 330
11. C Byrne C Schairer LA Brinton J Wolfe N Parekh M Salane C Carter R Hoover 2001 Effects of mammographic density and benign breast disease on breast cancer risk (United States) Cancer Causes Control 12 103 110
12. PA Carney DL Miglioretti BC Yankaskas K Kerlikowske R Rosenberg CM Rutter BM Geller LA Abraham SH Taplin M Dignan G Cutter R Ballard-Barbash 2003 Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography Ann Intern Med 138 168 175
13. CL Chen NS Weiss P Newcomb W Barlow E White 2002 Hormone replacement therapy in relation to breast cancer Jama 287 734 741
14. RT Chlebowski SL Hendrix RD Langer ML Stefanick M Gass D Lane RJ Rodabough MA Gilligan MG Cyr CA Thomson J Khandekar H Petrovitch A McTiernan 2003 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial Jama 289 3243 3253
15. M Clemons P Goss 2001 Estrogen and the risk of breast cancer N Engl J Med 344 276 285
16. GA Colditz SE Hankinson DJ Hunter WC Willett JE Manson MJ Stampfer C Hennekens B Rosner FE Speizer 1995 The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1589 1593
17. JR Daling KE Malone DR Doody LF Voigt L Bernstein RJ Coates PA Marchbanks SA Norman LK Weiss G Ursin JA Berlin RT Burkman D Deapen SG Folger JA McDonald MS Simon BL Strom PA Wingo R Spirtas 2002 Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma Cancer 95 2455 2464
18. AG Glass JV Lacey Jr. JD Carreon RN Hoover 2007 Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status J Natl Cancer Inst 99 1152 1161
19. GA Greendale BA Reboussin A Sie HR Singh LK Olson O Gatewood LW Bassett C Wasilauskas T Bush E Barrett-Connor 1999 Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators Ann Intern Med 130 262 269
20. MA Helvie C Paramagul HA Oberman DD Adler 1993 Invasive lobular carcinoma. Imaging features and clinical detection Invest Radiol 28 202 207
21. K Kerlikowske DL Miglioretti DS Buist R Walker PA Carney 2007 Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population J Natl Cancer Inst 99 1335 1339
22. KN Krecke JJ Gisvold 1993 Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients AJR Am J Roentgenol 161 957 960
23. F Levi VC Te L Randimbison C La Vecchia 2003 Increase in lobular breast cancer incidence in Switzerland Int J Cancer 107 164 165 author reply 166
24. CI Li BO Anderson JR Daling RE Moe 2002 Changing incidence of lobular carcinoma in situ of the breast Breast Cancer Res Treat 75 259 268
25. CI Li BO Anderson JR Daling RE Moe 2003 Trends in incidence rates of invasive lobular and ductal breast carcinoma Jama 289 1421 1424
26. CI Li KE Malone PL Porter NS Weiss MT Tang KL Cushing-Haugen JR Daling 2003 Relationship between long durations and different regimens of hormone therapy and risk of breast cancer Jama 289 3254 3263
27. CI Li KE Malone PL Porter NS Weiss MT Tang JR Daling 2003 Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age Int J Cancer 107 647 651
28. CI Li NS Weiss JL Stanford JR Daling 2000 Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women Cancer 88 2570 2577
29. E Lundstrom A Christow W Kersemaekers G Svane E Azavedo G Soderqvist M Mol-Arts J Barkfeldt B von Schoultz 2002 Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density Am J Obstet Gynecol 186 717 722
30. H Lyytinen E Pukkala O Ylikorkala 2006 Breast cancer risk in postmenopausal women using estrogen-only therapy Obstet Gynecol 108 1354 1360
31. J Manjer J Malina G Berglund L Bondeson JP Garne L Janzon 2001 Increased incidence of small and well-differentiated breast tumours in post-menopausal women following hormone-replacement therapy Int J Cancer 92 919 922
32. Y Nagao Y Kawaguchi Y Sugiyama S Saji Y Kashiki 2003 Relationship between mammographic density and the risk of breast cancer in Japanese women: a case-control study Breast Cancer 10 228 233
33. PA Newcomb L Titus-Ernstoff KM Egan A Trentham-Dietz JA Baron BE Storer WC Willett MJ Stampfer 2002 Postmenopausal estrogen and progestin use in relation to breast cancer risk Cancer Epidemiol Biomarkers Prev 11 593 600
34. LM Newcomer PA Newcomb JD Potter Y Yasui A Trentham-Dietz BE Storer MP Longnecker JA Baron JR Daling 2003 Postmenopausal hormone therapy and risk of breast cancer by histologic type (United States) Cancer Causes Control 14 225 233
35. PM Ravdin KA Cronin N Howlader CD Berg RT Chlebowski EJ Feuer BK Edwards DA Berry 2007 The decrease in breast-cancer incidence in 2003 in the United States N Engl J Med 356 1670 1674
36. GK Reeves V Beral J Green T Gathani D Bull 2006 Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis Lancet Oncol 7 910 918
37. LU Rosenberg C Magnusson E Lindstrom S Wedren P Hall PW Dickman 2006 Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study Breast Cancer Res 8 R11
38. JE Rossouw GL Anderson RL Prentice AZ LaCroix C Kooperberg ML Stefanick RD Jackson SA Beresford BV Howard KC Johnson JM Kotchen J Ockene 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial Jama 288 321 333
39. E Sala R Warren J McCann S Duffy R Luben N Day 2000 High-risk mammographic parenchymal patterns, hormone replacement therapy and other risk factors: a case-control study Int J Epidemiol 29 629 636
40. E Sala R Warren J McCann S Duffy R Luben N Day 2001 Mammographic parenchymal patterns and breast cancer natural history-a case-control study Acta Oncol 40 461 465
41. C Schairer J Lubin R Troisi S Sturgeon L Brinton R Hoover 2000 Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk Jama 283 485 491
42. VL Selinko LP Middleton PJ Dempsey 2004 Role of sonography in diagnosing and staging invasive lobular carcinoma J Clin Ultrasound 32 323 332
43. MJ Silverstein BS Lewinsky JR Waisman ED Gierson WJ Colburn GM Senofsky P Gamagami 1994 Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73 1673 1677
44. P Skaane F Skjorten 1999 Ultrasonographic evaluation of invasive lobular carcinoma Acta Radiol 40 369 375
45. A Tjonneland J Christensen BL Thomsen A Olsen K Overvad M Ewertz L Mellemkjaer 2004 Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study Cancer 100 2328 2337
46. G Ursin H Ma AH Wu L Bernstein M Salane YR Parisky M Astrahan CC Siozon MC Pike 2003 Mammographic density and breast cancer in three ethnic groups Cancer Epidemiol Biomarkers Prev 12 332 338
47. G Ursin CC Tseng A Paganini-Hill S Enger PC Wan S Formenti MC Pike RK Ross 2002 Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol 20 699 706
48. HM Verkooijen G Fioretta G Vlastos A Morabia H Schubert AP Sappino MF Pelte P Schafer J Kurtz C Bouchardy 2003 Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland Int J Cancer 104 778 781
49. Verkooijen HM, Koot VC, Fioretta G, van der Heiden M, Schipper ME, Rapiti E, Peeters PH, Peterse JL, Bouchardy C (2007) Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Breast Cancer Res Treat 107(3):389-395. Epub 13, March 2007
50. LK Weiss RT Burkman KL Cushing-Haugen LF Voigt MS Simon JR Daling SA Norman L Bernstein G Ursin PA Marchbanks BL Strom JA Berlin AL Weber DR Doody PA Wingo JA McDonald KE Malone SG Folger R Spirtas 2002 Hormone replacement therapy regimens and breast cancer risk(1) Obstet Gynecol 100 1148 1158
51. J Wohlfahrt H Mouridsen PK Andersen M Melbye 1999 Reproductive risk factors for breast cancer by receptor status, histology, laterality and location Int J Cancer 81 49 55
52. TJ Yeatman AB Cantor TJ Smith SK Smith DS Reintgen MS Miller NN Ku PA Baekey CE Cox 1995 Tumor biology of infiltrating lobular carcinoma. Implications for management Ann Surg 222 549 559 discussion 559-561